Cystic adenomyoma surgery.


Journal

Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 06 08 2021
revised: 05 01 2022
accepted: 10 01 2022
pubmed: 16 1 2022
medline: 25 2 2022
entrez: 15 1 2022
Statut: ppublish

Résumé

Cystic adenomyoma is a lesion located within the myometrium. It is lined with endometrium and has hemorrhagic content. This rare entity has been described as a focal form of adenomyosis. However, it is poorly understood, and the management of symptomatic patients is not codified. Our objective is to evaluate the effectiveness of treatment with planned surgery for cystic adenomyoma on symptoms and fertility in a retrospective series of patients. This is a retrospective study between January 2011 and January 2018 in a university hospital of patients that had surgery for cystic adenomyoma with uterine preservation. Pre-operative, per-operative, and post-operative data were recorded. Of the 18 patients included, 3 were lost to follow-up; 15 underwent laparoscopic surgery and 3 operative hysteroscopies. Complications during and after surgery were rare, involving only 3 patients, and of low severity. One patient saw no improvement in pain after surgery and 2 patients saw only partial improvement in their pain; 7 patients achieved at least one pregnancy with favorable outcome after surgery. Based on this series, we argue that conservative surgical treatment for cystic adenomyoma generally improves pain and fertility without causing morbidity.

Identifiants

pubmed: 35031510
pii: S2468-7847(22)00005-8
doi: 10.1016/j.jogoh.2022.102313
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102313

Informations de copyright

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Yohan Kerbage (Y)

Service de Chirurgie Gynécologique, CHU Lille, 1 Avenue Oscar Lambret, Lille F-59000, France; CHU Lille, University Lille, Lille F-59000, France. Electronic address: yohan.kerbage@chru-lille.fr.

Sarah Dericquebourg (S)

Service de Chirurgie Gynécologique, CHU Lille, 1 Avenue Oscar Lambret, Lille F-59000, France.

Pierre Collinet (P)

Service de Chirurgie Gynécologique, CHU Lille, 1 Avenue Oscar Lambret, Lille F-59000, France; CHU Lille, University Lille, Lille F-59000, France.

Pauline Verpillat (P)

Service d'imagerie de la Femme, CHU Lille, Lille F-59000, France.

Géraldine Giraudet (G)

Service de Chirurgie Gynécologique, CHU Lille, 1 Avenue Oscar Lambret, Lille F-59000, France.

Chrystèle Rubod (C)

Service de Chirurgie Gynécologique, CHU Lille, 1 Avenue Oscar Lambret, Lille F-59000, France; CHU Lille, University Lille, Lille F-59000, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH